Funded Grants

PI Name PI Organization Sort descending Title Grant Number Initiative Program Official
Liang, Han

University Of Tx Md Anderson Can Ctr
United States

The Cancer Proteome Atlas: an Integrated Bioinformatics Resource for Functional Cancer Proteomic Data 5U24CA264128-02 RFA-CA-21-015 (U24 Clinical Trial Optional)
Herrmann, Joerg

Mayo Clinic Rochester
United States

TrAstuzumab Cardiomyopathy Therapeutic Intervention with Carvedilol (TACTIC) Trial 5R01CA233610-06 PA-18-003 (R01 Clinical Trial Optional) Eileen Dimond, R.N., M.S.
Zhang, Fan

University Of Florida
United States

R21 MPI microRNA directed therapy for treating early stage pancreatic cancer 5R21CA277263-02
Lin, Jia-Ren

Harvard Medical School
United States

Advancing technologies for the collection and analysis of high dimensional immunoprofiles and tumor images 5R50CA274277-02 Richard Mazurchuk, Ph.D.
Shelby, Rebecca A

Duke University
United States

Persistent Post-Mastectomy Pain: Randomized Clinical Trial of Targeted Pain Coping Skills Training (Targeted-PCST) with Mediational Analysis 5R01CA249959-05 Brennan Streck, Ph.D., R.N., M.P.H.
Goggins, Michael G.

Johns Hopkins University
United States

Using markers to improve pancreatic cancer screening and surveillance: a multi-center study 5U01CA210170-07 PAR-21-334 (U01 Clinical Trial Optional) Matthew Young, Ph.D.
Hu, Shuiying

Ohio State University
United States

Prevention of paclitaxel-induced peripheral neuropathy with nilotinib 5R01CA238946-05 Rachel Altshuler, Ph.D.
Cheville, Andrea Lynne

Mayo Clinic Rochester
United States

Achieving Equity through SocioCulturally-informed, Digitally-Enabled Cancer Pain managemeNT” (ASCENT) Clinical Trial 4R33CA278594-02 Brennan Streck, Ph.D., R.N., M.P.H.
Hu, Shuiying

Ohio State University
United States

Prevention of paclitaxel-induced peripheral neuropathy with nilotinib 5R01CA238946-05 Rachel Altshuler, Ph.D.
Lee, Jeffrey Kuang Zou

Kaiser Foundation Research Institute
United States

Multi-Ethnic Multi-Cancer Early Detection and Screening (MED SCREEN) Study 1UG1CA287011-01 Elyse LeeVan, M.D., M.P.H.